Novel Hydroxychalcone-Based Dual Inhibitors of Aldose Reductase and α-Glucosidase as Potential Therapeutic Agents against Diabetes Mellitus and Its Complications-Reference-Cited by-同舟云学术

Novel Hydroxychalcone-Based Dual Inhibitors of Aldose Reductase and α-Glucosidase as Potential Therapeutic Agents against Diabetes Mellitus and Its Complications

Published:2022-06-24 Issue:13 Volume:65 Page:9174-9192
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Zhang Xiaonan¹,Xu Long¹,Chen Huan¹,Zhang Xin¹,Lei Yanqi¹,Liu Wenchao¹,Xu Hulin¹,Ma Bing¹^ORCID,Zhu Changjin¹

Affiliation:

1. Key Laboratory of Cluster Science, Ministry of Education of China, Beijing Key Laboratory of Photoelectronic; Electrophotonic Conversion Materials, School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing 100081, China

Funder

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c00380

Reference65 articles.

1. Current anti-diabetic agents and their molecular targets: A review

2. Biochemistry and molecular cell biology of diabetic complications

3. Is Type 2 Diabetes an Operable Intestinal Disease?